Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Sosei Group announces Formosa Pharmaceuticals has received approval from the FDA of its IND application for APP13007 to commence a first-in-human clinical trial in the United States.
read more
Boehringer Ingelheim and Bridge Biotherapeutics announced they are entering into a new collaboration and license agreement with the goal of developing autotaxin inhibitor BBT-877.
read more
CenExel Clinical Research announced the creation of their Centers of Excellence company, which unites four clinical research units in the country to design and execute Phase I-IV trials.
read more
Catalent has appointed Ricardo Pravda as Senior Vice President and Chief Human Resources (HR) Officer.
read more
Lonza has selected Rockwell Automation for the turnkey implementation of the Lonza strategic vision of bringing the digital factory to nine former Capsugel facilities that manufacture drug capsules.
read more
Anixa Biosciences has established a strategic alliance and license agreement with Cleveland Clinic for breast cancer vaccine technology.
read more
NorthStar Medical Radioisotopes announced completion of construction on its 20,000 square foot Mo-99 processing facility in Beloit, Wis., with equipment installation currently underway.
read more
Optimal Just-in-Time and CTCA are collaborating to speed patient enrollment in oncology clinical trials.
read more
As drug manufacturing has globalized, ensuring that companies meet the FDA strict standards for producing safe, effective and high-quality medicines has become increasingly challenging.
read more
Gotham Therapeutics and Mercachem announced the generation of a compound library for accelerated hit generation and hit-to-lead expansion against large parts of the epitranscriptomic target space.
read more
Catalent Biologics announced a long-term strategic agreement for the development and manufacturing of Zolgensma®, an AveXis gene therapy treatment for spinal muscular atrophy.
read more
Genomma Lab has announced the Mexican Federal COFEPRIS has granted the Sanitary License which permits the Company's new manufacturing facility to begin operations.
read more
Leading Edge Pharms announced a distribution deal with MarketHub Retail Services, a distribution network focusing on hemp-based health products.
read more
Colorcon has announced its investment to build a new starch manufacturing plant close to Amsterdam in The Netherlands.
read more
Sun Pharmaceutical announced the U.S. launch of Ezallor Sprinkle™ capsules for the treatment of three types of elevated lipid disorders in people who have difficulty swallowing.
read more